BPC-157: More localized, especially in the GI tract and connective tissue TB-500: Broader systemic effects, influencing cell migration and circulation In some cases, both may be considered together (bpc157 and tb500) as complementary, though decisions must be individualized and physician-guided
The Croatian Phase I and II clinical trials for inflammatory bowel disease conducted in the 1990s by pharmaceutical company Pliva claimed safety with no significant toxicity, though complete peer-reviewed data never appeared in scientific literature beyond conference abstracts
This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision
This application area aligns with the structural origin of the compound and remains an active area of in-vitro literature
Standard angiogenic factors like VEGF primarily accelerate growth without this built-in regulatory mechanism
However, tendons are also susceptible to injury and can often be slow to heal
